低频EEG功率和一致性在药物诱导的帕金森症和帕金森病之间有所不同
Seungbeom Seo1, Sunmin Kim2, Sung-Phil Kim2
1Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan, South Korea; Department of Electrical Engineering, Ulsan National Institute of Science and Technology, Ulsan, South Korea.
概括
休息状态EEG揭示了明确的神经模式,区分药物诱导的帕金森病 (DIP) 和帕金森病 (PD). DIP患者表现出改变的甲功率和三角连贯性,这表明EEG作为诊断工具.
科学领域:
- 神经科学是一个神经科学.
- 临床神经学 临床神经学
- 生物医学工程 生物医学工程
背景情况:
- 药物诱导的帕金森症 (DIP) 是帕金森症的一个重要原因,通常表现出与帕金森病 (PD) 类似的症状.
- 准确区分DIP和PD对于适当的患者管理和治疗至关重要.
- 静止电脑图 (rsEEG) 提供了一种潜在的非侵入性方法,用于识别神经标记物以进行差异诊断.
研究的目的:
- 为了研究和比较使用rsEEG在DIP和PD患者的神经标志物.
- 确定特定的rsEEG光谱功率和通道间连贯性模式,以区分DIP和PD.
主要方法:
- 对15名DIP患者,41名新发PD患者和12名健康对照 (HC) 的rsEEG数据进行了回顾性分析.
- 在这三个组中,对EEG光谱功率进行比较,重点关注和三角波段.
- 分析三角洲频段的道间连贯性,以确定特定组的差异.
主要成果:
- 在DIP,PD和HC组之间观察到rsEEG模式的显著差异.
- 与PD患者和HC患者相比,DIP患者的Theta带功率显著增加.
- 与PD患者相比,DIP患者表现出明显更高的三角波段一致性.
结论:
- rsEEG可以有效地突出DIP和PD之间神经活动的差异.
- 该研究表明rsEEG是一个有前途的工具,可以根据不同的光谱和连贯性模式区分DIP和PD.
- 这些发现有助于开发帕金森症亚型的客观诊断标记.
相关概念视频
01:24Parkinson's Disease: Treatment
222
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
222
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
01:15Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482